Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Pfizer lung cancer drug achieves Phase 3 endpoint
Pfizer lung cancer drug achieves Phase 3 endpoint
Pfizer lung cancer drug achieves Phase 3 endpoint
Submitted by
admin
on June 19, 2012 - 10:15am
Source:
Marketwatch
News Tags:
Pfizer
lung cancer
Xalkori
Headline:
Pfizer lung cancer drug achieves Phase 3 endpoint
Do Not Allow Advertisers to Use My Personal information
